Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.
BACKGROUND
Proton pump inhibitors (PPIs) are frequently prescribed for prophylaxis of nosocomial upper gastrointestinal tract bleeding. Some inpatients receiving PPIs may have no risk factors for nosocomial upper gastrointestinal tract bleeding, and PPIs may be continued unnecessarily at hospital discharge. We aimed to assess the effect of standardized guidelines on PPI prescribing practices.


METHODS
Guidelines for PPI use were implemented on the medical service at a tertiary center. We reviewed PPI use among inpatient admissions during the month before implementation of guidelines and then prospectively evaluated PPI use among admissions during the month after implementation of guidelines.


RESULTS
Among an overall cohort of 942 patients, 48% were prescribed PPIs while inpatients, and 41% were prescribed PPIs at hospital discharge. Univariate predictors of inpatient PPI use included age, length of hospital stay, history of gastroesophageal reflux disease or upper gastrointestinal tract bleeding, and outpatient PPI, aspirin, or glucocorticoid use. Among patients not on an outpatient regimen of PPIs at admission, implementation of guidelines resulted in lower rates of inpatient PPI use (27% before vs 16% after, P = .001) and PPI prescription at discharge (16% before vs 10% after, P = .03).


CONCLUSIONS
Introduction of standardized guidelines resulted in lower rates of PPI use among a subset of inpatients and reduced the rate of PPI prescriptions at discharge.
Yachimski
Patrick S
PS
Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. patrick.yachimski@vanderbilt.edu
Farrell
Elizabeth A
EA
Hunt
Daniel P
DP
Reid
Andrea E
AE
D001900:Boston; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D019983:Guideline Adherence; D006801:Humans; D007297:Inpatients; D016015:Logistic Models; D008297:Male; D008505:Medical Staff, Hospital; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011446:Prospective Studies; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
D054328:Proton Pump Inhibitors
Am J Gastroenterol. 2006 Oct;101(10):2200-5
16952283
Am J Gastroenterol. 2009 Mar;104 Suppl 2:S17-20
19262541
BMC Health Serv Res. 2007 Nov 05;7:177
17983477
Am J Gastroenterol. 2008 Sep;103(9):2308-13
18702653
N Engl J Med. 1998 Mar 19;338(12):791-7
9504939
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1261-6
16804095
Am J Gastroenterol. 2009 Mar;104 Suppl 2:S10-6
19262540
Am J Gastroenterol. 2000 Nov;95(11):3118-22
11095327
Ann Intern Med. 2008 Sep 16;149(6):391-8
18794558
BMC Med Inform Decis Mak. 2009 Feb 11;9:11
19210782
Chest. 2009 Aug;136(2):440-447
19318661
JAMA. 2009 May 27;301(20):2120-8
19470989
J Clin Gastroenterol. 2008 Apr;42(4):368-72
18277903
JAMA. 2005 Dec 21;294(23):2989-95
16414946
Eur J Gastroenterol Hepatol. 2008 Jul;20(7):608-12
18679061
Aliment Pharmacol Ther. 2009 Mar 15;29(6):626-34
19183143
J Am Med Dir Assoc. 2007 Nov;8(9):607-9
17998118
Aliment Pharmacol Ther. 2005 May 15;21(10):1203-9
15882240
N Engl J Med. 1994 Feb 10;330(6):377-81
8284001
JAMA. 2006 Dec 27;296(24):2947-53
17190895
JAMA. 2009 Mar 4;301(9):937-44
19258584
Am J Gastroenterol. 2009 Mar;104 Suppl 2:S2-4
19262542